Ftse Mib
34.657,35
0,93%
DAX
18.772,85
0,50%
S&P 500
5.222,68
0,16%
NASDAQ
16.340,87
-0,03%
Bitcoin
61.017,22
0,36%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Seer Inc (SEER) Seer Inc (SEER) Notizie

Seer Inc

SEER
1,995
-0,065 (-3,16%)
11 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
08/5/202422:35EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/5/202422:15EDGAR2Form 8-K - Current report
08/5/202422:05GLOBESeer Reports First Quarter 2024 Financial Results
08/5/202422:03GLOBESeer Launches New Technology Access Center in Europe to..
23/4/202422:05GLOBESeer to Report First Quarter 2024 Financial Results on May..
06/3/202422:14EDGAR2Form S-8 - Securities to be offered to employees in employee..
29/2/202422:15EDGAR2Form 8-K - Current report
29/2/202422:05GLOBESeer Reports Fourth Quarter and Full Year 2023 Financial..
23/2/202423:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202422:05GLOBESeer to Participate in the TD Cowen 44th Annual Health Care..
08/2/202403:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202414:00GLOBESeer Proteograph™ Enables Unprecedented Genetic Marker..
01/2/202422:05GLOBESeer to Report Fourth Quarter and Full Year 2023 Financial..
03/1/202414:52EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
22/12/202322:10EDGAR2Form 8-K - Current report
21/12/202322:05GLOBESeer to Present at the J.P. Morgan 42nd Annual Health Care..
17/11/202322:58EDGAR2Form 8-K - Current report
10/11/202315:00GLOBESeer to Present at the Canaccord MedTech, Diagnostics and..
08/11/202315:00GLOBESeer Wins Proteomics Solution of the Year by BioTech..
07/11/202322:25EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202322:18EDGAR2Form 8-K - Current report
07/11/202322:05GLOBESeer Reports Third Quarter 2023 Financial Results
01/11/202314:00GLOBESeer Announces Addition of Panome Bio to Centers of..
19/10/202322:05GLOBESeer to Report Third Quarter 2023 Financial Results on..
08/9/202322:05GLOBESeer to Participate in Upcoming September Investor..
08/8/202322:21EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202322:15EDGAR2Form 8-K - Current report
08/8/202322:05GLOBESeer Reports Second Quarter 2023 Financial Results
27/7/202322:05GLOBESeer to Present at the Canaccord Genuity 43rd Annual Growth..
21/7/202322:29EDGAR2Form 8-K - Current report
13/7/202322:05GLOBESeer to Report Second Quarter 2023 Financial Results on..
07/6/202315:00GLOBESeer Collaborates to Make Scalable, Unbiased Proteomics..
01/6/202315:00GLOBESeer Launches the Proteograph XT Assay Kit: Allowing Labs to..
Apertura: 2,05 Min: 1,98 Max: 2,08
Chiusura: 2,06

La tua Cronologia

NASDAQ
SEER
Seer
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network